Click for best price
Biosimilars/followonbiologics Market Size, Share 2022
This report contains market size and forecasts of Biosimilars/follow-on-biologics in Global, including the following market information:
Global Biosimilars/follow-on-biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilars/follow-on-biologics market was valued at 9560.2 million in 2021 and is projected to reach US$ 11700 million by 2028, at a CAGR of 2.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human growth hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilars/follow-on-biologics include Novartis (Sandoz), Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck Serono (Merck), Biogen idec and Genentech (Roche). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilars/follow-on-biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars/follow-on-biologics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, by Type, 2021 (%)
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Global Biosimilars/follow-on-biologics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, by Application, 2021 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars/follow-on-biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilars/follow-on-biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars/follow-on-biologics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilars/follow-on-biologics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
| Report Attributes |
Report Details |
| Report Title |
Biosimilars/follow-on-biologics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilars/follow-on-biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars/follow-on-biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars/follow-on-biologics Overall Market Size
2.1 Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2028
2.2 Global Biosimilars/follow-on-biologics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilars/follow-on-biologics Players in Global Market
3.2 Top Global Biosimilars/follow-on-biologics Companies Ranked by Revenue
3.3 Global Biosimilars/follow-on-biologics Revenue by Companies
3.4 Top 3 and Top 5 Biosimilars/follow-on-biologics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilars/follow-on-biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilars/follow-on-biologics Players in Global Market
3.6.1 List of Global Tier 1 Biosimilars/follow-on-biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilars/follow-on-biologics Market Size Markets, 2021 & 2028
4.1.2 Human growth hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Others
4.2 By Type - Global Biosimilars/follow-on-biologics Revenue & Forecasts
4.2.1 By Type - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
4.2.2 By Type - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
4.2.3 By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2028
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application - Global Biosimilars/follow-on-biologics Revenue & Forecasts
5.2.1 By Application - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
5.2.2 By Application - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
5.2.3 By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilars/follow-on-biologics Market Size, 2021 & 2028
6.2 By Region - Global Biosimilars/follow-on-biologics Revenue & Forecasts
6.2.1 By Region - Global Biosimilars/follow-on-biologics Revenue, 2017-2022
6.2.2 By Region - Global Biosimilars/follow-on-biologics Revenue, 2023-2028
6.2.3 By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilars/follow-on-biologics Revenue, 2017-2028
6.3.2 US Biosimilars/follow-on-biologics Market Size, 2017-2028
6.3.3 Canada Biosimilars/follow-on-biologics Market Size, 2017-2028
6.3.4 Mexico Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilars/follow-on-biologics Revenue, 2017-2028
6.4.2 Germany Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.3 France Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.4 U.K. Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.5 Italy Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.6 Russia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilars/follow-on-biologics Market Size, 2017-2028
6.4.8 Benelux Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilars/follow-on-biologics Revenue, 2017-2028
6.5.2 China Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.3 Japan Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.4 South Korea Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.5.6 India Biosimilars/follow-on-biologics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilars/follow-on-biologics Revenue, 2017-2028
6.6.2 Brazil Biosimilars/follow-on-biologics Market Size, 2017-2028
6.6.3 Argentina Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, 2017-2028
6.7.2 Turkey Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.3 Israel Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilars/follow-on-biologics Market Size, 2017-2028
6.7.5 UAE Biosimilars/follow-on-biologics Market Size, 2017-2028
7 Players Profiles
7.1 Novartis (Sandoz)
7.1.1 Novartis (Sandoz) Corporate Summary
7.1.2 Novartis (Sandoz) Business Overview
7.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Major Product Offerings
7.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.1.5 Novartis (Sandoz) Key News
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Corporate Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.2.5 Synthon Pharmaceuticals Key News
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Corporate Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceutical Industries Key News
7.4 LG Life Sciences
7.4.1 LG Life Sciences Corporate Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars/follow-on-biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.4.5 LG Life Sciences Key News
7.5 Celltrion Biocon
7.5.1 Celltrion Biocon Corporate Summary
7.5.2 Celltrion Biocon Business Overview
7.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Major Product Offerings
7.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.5.5 Celltrion Biocon Key News
7.6 Hospira
7.6.1 Hospira Corporate Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Biosimilars/follow-on-biologics Major Product Offerings
7.6.4 Hospira Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.6.5 Hospira Key News
7.7 Merck Serono (Merck)
7.7.1 Merck Serono (Merck) Corporate Summary
7.7.2 Merck Serono (Merck) Business Overview
7.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Major Product Offerings
7.7.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.7.5 Merck Serono (Merck) Key News
7.8 Biogen idec
7.8.1 Biogen idec Corporate Summary
7.8.2 Biogen idec Business Overview
7.8.3 Biogen idec Biosimilars/follow-on-biologics Major Product Offerings
7.8.4 Biogen idec Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.8.5 Biogen idec Key News
7.9 Genentech (Roche)
7.9.1 Genentech (Roche) Corporate Summary
7.9.2 Genentech (Roche) Business Overview
7.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Major Product Offerings
7.9.4 Genentech (Roche) Biosimilars/follow-on-biologics Revenue in Global Market (2017-2022)
7.9.5 Genentech (Roche) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biosimilars/follow-on-biologics Market Opportunities & Trends in Global Market
Table 2. Biosimilars/follow-on-biologics Market Drivers in Global Market
Table 3. Biosimilars/follow-on-biologics Market Restraints in Global Market
Table 4. Key Players of Biosimilars/follow-on-biologics in Global Market
Table 5. Top Biosimilars/follow-on-biologics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilars/follow-on-biologics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilars/follow-on-biologics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilars/follow-on-biologics Product Type
Table 9. List of Global Tier 1 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars/follow-on-biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilars/follow-on-biologics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilars/follow-on-biologics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2023-2028
Table 30. Novartis (Sandoz) Corporate Summary
Table 31. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offerings
Table 32. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 33. Synthon Pharmaceuticals Corporate Summary
Table 34. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offerings
Table 35. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Industries Corporate Summary
Table 37. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offerings
Table 38. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 39. LG Life Sciences Corporate Summary
Table 40. LG Life Sciences Biosimilars/follow-on-biologics Product Offerings
Table 41. LG Life Sciences Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 42. Celltrion Biocon Corporate Summary
Table 43. Celltrion Biocon Biosimilars/follow-on-biologics Product Offerings
Table 44. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 45. Hospira Corporate Summary
Table 46. Hospira Biosimilars/follow-on-biologics Product Offerings
Table 47. Hospira Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 48. Merck Serono (Merck) Corporate Summary
Table 49. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offerings
Table 50. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 51. Biogen idec Corporate Summary
Table 52. Biogen idec Biosimilars/follow-on-biologics Product Offerings
Table 53. Biogen idec Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
Table 54. Genentech (Roche) Corporate Summary
Table 55. Genentech (Roche) Biosimilars/follow-on-biologics Product Offerings
Table 56. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biosimilars/follow-on-biologics Segment by Type in 2021
Figure 2. Biosimilars/follow-on-biologics Segment by Application in 2021
Figure 3. Global Biosimilars/follow-on-biologics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilars/follow-on-biologics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilars/follow-on-biologics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2021
Figure 8. By Type - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 12. US Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 24. China Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilars/follow-on-biologics Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilars/follow-on-biologics Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LG Life Sciences Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltrion Biocon Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hospira Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biogen idec Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Genentech (Roche) Biosimilars/follow-on-biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
